Indivior Plc Spon Company Profile (NASDAQ:INVVY)

About Indivior Plc Spon (NASDAQ:INVVY)

Indivior Plc Spon logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INVVY
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $20.97
  • 200 Day Moving Avg: $20.32
  • 52 Week Range: $11.94 - $23.30
P/E:
  • Trailing P/E Ratio: 45.67
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $1.07 billion
  • Price / Sales: N/A
  • Book Value: ($1.47) per share
  • Price / Book: -13.98
Dividend:
  • Dividend Yield: 4.5%
Profitability:
  • EBIDTA: $202 million
Misc:
  • Average Volume: 819 shs.
 

Frequently Asked Questions for Indivior Plc Spon (NASDAQ:INVVY)

What is Indivior Plc Spon's stock symbol?

Indivior Plc Spon trades on the NASDAQ under the ticker symbol "INVVY."

Who are some of Indivior Plc Spon's key competitors?

How do I buy Indivior Plc Spon stock?

Shares of Indivior Plc Spon can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Indivior Plc Spon's stock price today?

One share of Indivior Plc Spon stock can currently be purchased for approximately $20.55.


MarketBeat Community Rating for Indivior Plc Spon (NASDAQ INVVY)
Community Ranking:  1.4 out of 5 ()
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Indivior Plc Spon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Indivior Plc Spon (NASDAQ:INVVY) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Indivior Plc Spon (NASDAQ:INVVY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Indivior Plc Spon (NASDAQ:INVVY)
Earnings by Quarter for Indivior Plc Spon (NASDAQ:INVVY)
Earnings History by Quarter for Indivior Plc Spon (NASDAQ INVVY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2017Q4$0.35$259.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Indivior Plc Spon (NASDAQ:INVVY)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Indivior Plc Spon (NASDAQ:INVVY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Indivior Plc Spon (NASDAQ:INVVY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Indivior Plc Spon (NASDAQ:INVVY)
Latest Headlines for Indivior Plc Spon (NASDAQ:INVVY)
Source:
DateHeadline
americanbankingnews.com logoZacks: Indivior Plc Spon (INVVY) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - May 29 at 9:20 AM
finance.yahoo.com logoETFs with exposure to Indivior Plc : May 16, 2017
finance.yahoo.com - May 16 at 5:51 PM
finance.yahoo.com logoIndivior Plc :INVVY-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 5:36 PM
americanbankingnews.com logoZacks Investment Research Upgrades Indivior Plc Spon (INVVY) to "Strong-Buy"
www.americanbankingnews.com - May 6 at 12:36 AM
americanbankingnews.com logoIndivior Plc Spon (INVVY) Upgraded by Zacks Investment Research to "Strong-Buy"
www.americanbankingnews.com - May 6 at 12:32 AM
seekingalpha.com logoIndivior's (INVVY) CEO Shaun Thaxter on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 11:14 AM
americanbankingnews.com logoZacks: Indivior Plc Spon (INVVY) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - May 1 at 6:14 PM
americanbankingnews.com logoIndivior Plc Spon (INVVY) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 9 at 9:32 PM
americanbankingnews.com logoIndivior Plc Spon (INVVY) Expected to Announce Quarterly Sales of $0.00
www.americanbankingnews.com - April 8 at 9:02 AM
americanbankingnews.com logoZacks: Indivior Plc Spon (INVVY) Receives Average Recommendation of "" from Analysts
www.americanbankingnews.com - March 22 at 11:22 AM
seekingalpha.com logoINDIVIOR PLC ADR 2016 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 22 at 12:38 PM
ft.com logo[$$] Rolls-Royce shares buoyed by Citi upgrade
www.ft.com - February 7 at 7:14 PM
uk.finance.yahoo.com logoINVVY Key statistics | INDIVIOR PLC SPON ADR EA REPR 5 Stock - Yahoo Finance
uk.finance.yahoo.com - January 21 at 5:46 PM
finance.yahoo.com logoTop Ranked Momentum Stocks to Buy for November 17th
finance.yahoo.com - November 17 at 8:58 AM
thestreet.com logoStates Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics
www.thestreet.com - September 23 at 8:36 AM
thestreet.com logoEuropean Markets Down Ahead of Fed Minutes
www.thestreet.com - August 17 at 5:52 PM
thestreet.com logoEuropean Markets Open Mostly Down; ASML Falls on Intel Snub
www.thestreet.com - August 17 at 8:43 AM
finance.yahoo.com logoIndivior to Present New Data at ISPOR and ICOO that Assess Implications of Adherence, Healthcare Service Utilization and Costs in Opioid Use Disorder
finance.yahoo.com - May 20 at 11:29 AM
finance.yahoo.com logoIndivior Presents Late-Breaking, Real-World Data Revealing Less than Half of Patients with Opioid Use Disorder Receive Medication-Assisted Treatment
finance.yahoo.com - April 15 at 12:00 PM
uk.finance.yahoo.com logoQuestor share tip: Sell Indivior after a wild first year on the stock market
uk.finance.yahoo.com - February 18 at 1:39 PM
uk.finance.yahoo.com logoIndivior lifts profits but promises last dividend for foreseeable future
uk.finance.yahoo.com - February 18 at 4:26 AM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
finance.yahoo.com - November 25 at 9:30 AM
finance.yahoo.com logo5 Cheap Health Care Stocks that Promise Healthy Returns
finance.yahoo.com - November 24 at 11:47 AM
finance.yahoo.com logoIndivior Applauds Recent Momentum to Address Opioid Dependence and Overdose Epidemic
finance.yahoo.com - October 21 at 9:35 PM
finance.yahoo.com logoIndivior PLC Responds to Court's Decision on Motion to Amend
finance.yahoo.com - October 12 at 8:10 AM
finance.yahoo.com logoLannett Company (LCI) Looks Good: Stock Gains 12.8%
finance.yahoo.com - September 4 at 9:46 AM
finance.yahoo.com logoApricus Biosciences (APRI) Looks Good: Stock Gains 9.8%
finance.yahoo.com - August 31 at 9:25 AM
finance.yahoo.com logoIndivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review
finance.yahoo.com - July 29 at 8:00 AM

Social

Chart

Indivior Plc Spon (INVVY) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff